Medication info
Yutofen Tablet

Yutofen Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›18.75mg / 1 tablet
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200805812 · Notified 2008.05.26 · Insurance code 640004590

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 4 tablets is recommended. Subsequent doses should be given at intervals of at least 6 hours, and the dose should not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment should be continued. Older adults Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years and over, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, an additional dose of this drug is not needed after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 4 tablets is recommended. Subsequent doses should be given at intervals of at least 6 hours, and the dose should not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment should be continued.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute and chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 4 tablets is recommended. Subsequent doses should be given at intervals of at least 6 hours, and the dose should not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment should be continued. Older adults Administer the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to older adults aged 75 years and over, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, an additional dose of this drug is not needed after dialysis to maintain analgesia. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 4 tablets is recommended. Subsequent doses should be given at intervals of at least 6 hours, and the dose should not exceed 16 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, conduct regular monitoring to determine whether treatment should be continued.

Precautions

This medication may put a strain on the liver, so individuals who consume alcohol regularly should consult with their doctor or pharmacist. If you experience a rash or hypersensitivity reaction during treatment, discontinue use immediately and seek medical attention. Take caution if you have a history of seizures or are taking medications that may induce seizures, as there is a risk of seizures. Patients with severe respiratory diseases should be administered this medication in a controlled environment, as it may suppress breathing. Avoid concomitant use of this medication with alcohol or central nervous system depressants, as it may lead to severe sedation or respiratory suppression. Patients with head injuries or brain disorders should be cautious when taking this medication due to the risk of increased intracranial pressure. This medication may induce physical and psychological dependence; therefore, monitoring for dependency is necessary during prolonged use. Patients with liver impairment must consult a physician before taking this medication, and should not exceed the recommended dose due to the risk of liver damage. CYP2D6 ultra-rapid metabolizers may have increased levels of the active metabolites of this medication, raising the risk of respiratory suppression; caution is warranted. This medication is not to be administered to children under 12 years old or to adolescents under 18 years who have undergone tonsillectomy or adenoidectomy. Patients with sleep apnea or hypoxia should be continuously monitored for worsening symptoms after taking this medication and should reduce the dose or discontinue use if necessary. This medication may cause drowsiness or dizziness, thus caution is advised while driving or operating machinery. In cases of overdose, severe respiratory suppression, seizures, liver damage, etc., immediate emergency treatment is required. This medication may interact with various other medications, so be sure to inform your healthcare provider of any other medications you are taking. If you are pregnant or breastfeeding, consult your physician before taking this medication; it is particularly advised for nursing mothers to discontinue breastfeeding while on this medication. Keep this medication out of the reach of children, and ensure it is stored in a secure place to prevent misuse or abuse.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, hepatotoxicity, hyponatremia, decreased appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, excitement, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory loss, tremors, paresthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, diaphoresis, urinary dysfunction, erectile dysfunction, asthenia, chest pain, emotional abnormalities, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylactic reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, emotional instability, delirium, suicidal thoughts, hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hyperglutamic acidosis, high anion gap metabolic acidosis, fixed rash, asthenia, fever, edema, rigidity, syncope, congestive heart failure, confusion, exacerbation of migraine, involuntary muscle contractions, respiratory distress, cough, bronchitis, urinary retention, frequency of urination, abnormal renal function tests, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of stomach cancer, paralytic ileus, hiccups, cholecystitis, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities, nausea, dizziness, confusion, dyspnea, disorientation, multiple organ failure, intentional overdose, belching, chest discomfort, withdrawal symptoms, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory syndrome, ptyalism, excitement, nervousness, hyperactivity, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system reactions, urticaria, rash, bronchospasms, toxic skin necrosis, anaphylaxis, seizures, serotonin syndrome, serotonin syndrome, myocardial infarction, QT prolongation, abdominal discomfort, lethargy, pallor, diaphoresis, respiratory depression, somnolence, coma, recurrence of myocardial infarction, hypotension, bleeding

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture entry, ideally at room temperature between 1°C and 30°C. Storing it this way will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.